{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T16:44:26Z","timestamp":1757781866492,"version":"3.41.0"},"reference-count":201,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.clindermatol.2018.03.013","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T03:28:32Z","timestamp":1522294112000},"page":"399-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dangerous plants in dermatology: Legal and controlled"],"prefix":"10.1016","volume":"36","author":[{"given":"Deeptej","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliya","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devorah","family":"Shagalov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakaash","family":"Varma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel M.","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2018.03.013_bb0005","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jep.2015.10.025","article-title":"Global medicinal uses of Euphorbia L. (Euphorbiaceae)","volume":"176","author":"Ernst","year":"2015","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.fitote.2014.07.002","article-title":"The value of nature\u2019s natural product library for the discovery of New Chemical Entities: the discovery of ingenol mebutate","volume":"98","author":"Ogbourne","year":"2014","journal-title":"Fitoterapia"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0030","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMra023160","article-title":"Drug addiction","volume":"349","author":"Cam\u00ed","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0035","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1021\/acs.jnatprod.5b00949","article-title":"Evolution of the cannabinoid and terpene content during the growth of Cannabis sativa plants from different chemotypes","volume":"79","author":"Aizpurua-olaizola","year":"2016","journal-title":"J Nat Prod"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0040","doi-asserted-by":"crossref","first-page":"605-313","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0045","first-page":"1069","article-title":"Cannabinoids as therapeutics for non-melanoma and melanoma skin cancer","volume":"4","author":"Soliman","year":"2016","journal-title":"J Dermatol Clin Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0050","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/jamadermatol.2015.6120","article-title":"Cannabis and Dr Piffard\u2014a century ahead of the curve","volume":"152","author":"Theroux","year":"2016","journal-title":"JAMA Dermatol"},{"year":"1881","series-title":"A Treatise on the Materia Medica and Therapeutics of the Skin","author":"Piffard","key":"10.1016\/j.clindermatol.2018.03.013_bb0055"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jama.2016.18900","article-title":"Use of marijuana for medical purposes among adults in the United States","volume":"317","author":"Compton","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0065","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1172\/JCI64628","article-title":"Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes","volume":"124","author":"Ol\u00e1h","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0070","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/exd.13042","article-title":"Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry\/seborrhoeic skin and acne treatment","volume":"25","author":"Ol\u00e1h","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jdermsci.2006.10.009","article-title":"Cannabinoids inhibit human keratinocyte proliferation through a non-CB1\/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis","volume":"45","author":"Wilkinson","year":"2007","journal-title":"J Dermatolog Sci"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0080","doi-asserted-by":"crossref","first-page":"AB28","DOI":"10.1016\/j.jaad.2015.02.126","article-title":"Cannabinoid receptors: their impact in epidermal differentiation and possible role in treatment of psoriasis","volume":"72","author":"Kim","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaad.2015.04.060","article-title":"Neurocutaneous disease","volume":"74","author":"Chuquilin","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/jpet.108.150136","article-title":"Endocannabinoid modulation of scratching response in an acute allergenic model: a new prospective neural therapeutic target for pruritus","volume":"329","author":"Schlosburg","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0095","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1189\/jlb.3A0115-030RR","article-title":"\u03949-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells","volume":"98","author":"Sido","year":"2015","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0100","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/all.12183","article-title":"Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors","volume":"68","author":"Gaffal","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0105","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1398-9995.2009.02254.x","article-title":"Protective role of palmitoylethanolamide in contact allergic dermatitis","volume":"65","author":"Petrosino","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lfs.2015.04.003","article-title":"Differential role of cannabinoids in the pathogenesis of skin cancer","volume":"138","author":"Glodde","year":"2015","journal-title":"Life Sci"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0115","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/annrheumdis-2011-200314","article-title":"Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis","volume":"71","author":"Gonzalez","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0130","series-title":"Itch","first-page":"115","author":"Yosipovitch","year":"2004"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1365-2133.2002.04803.x","article-title":"Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis","volume":"147","author":"Toyoda","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0140","first-page":"1389","article-title":"The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content","volume":"28","author":"Ali","year":"2015","journal-title":"Pak J Pharm Sci"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.prostaglandins.2009.07.001","article-title":"Receptors for acylethanolamides\u2014GPR55 and GPR119","volume":"89","author":"Godlewski","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0150","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1213\/ANE.0b013e3182707859","article-title":"CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system","volume":"116","author":"Romero","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0155","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.imbio.2009.09.007","article-title":"Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease","volume":"215","author":"O\u2019Sullivan","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0160","first-page":"97","article-title":"Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study","volume":"13","author":"Szepietowski","year":"2005","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-3083.2007.02351.x","article-title":"Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study)","volume":"22","author":"Eberlein","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0170","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00105-006-1180-1","article-title":"Topische cannabinoidagonisten","volume":"57","author":"St\u00e4nder","year":"2006","journal-title":"Hautarzt"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09546630510035832","article-title":"Efficacy of dietary hempseed oil in patients with atopic dermatitis","volume":"16","author":"Callaway","year":"2005","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0190","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1600-0625.2009.00923.x","article-title":"Cannabinoid system in the skin\u2014a possible target for future therapies in dermatology","volume":"18","author":"Kupczyk","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0195","first-page":"829","article-title":"Allergic skin test reactivity to marijuana in the Southwest","volume":"138","author":"Freeman","year":"1983","journal-title":"West J Med"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S1081-1206(10)62473-8","article-title":"Cannabis (hemp) positive skin tests and respiratory symptoms","volume":"85","author":"Stokes","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0205","doi-asserted-by":"crossref","first-page":"AB178","DOI":"10.1016\/j.jaci.2010.12.707","article-title":"Hypersensitivity reactions to marijuana","volume":"127","author":"Basharat","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0210","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1067\/mai.2003.1591","article-title":"Anaphylaxis to ingestion of hempseed (Cannabis sativa)","volume":"112","author":"Stadtmauer","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0215","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1111\/add.13826","article-title":"Cannabis, psychosis and schizophrenia: unravelling a complex interaction","volume":"112","author":"Hamilton","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0220","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.0105-1873.2006.0560h.x","article-title":"Contact urticaria to Cannabis sativa","volume":"54","author":"Majmudar","year":"2006","journal-title":"Contact Dermat"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0225","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-219111","article-title":"Cannabis arteritis: ever more important to consider","volume":"2017","author":"Santos","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0230","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1158\/1535-7163.1651.3.12","article-title":"Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor\u2013related apoptosis-inducing ligand\u2013induced apoptosis in melanoma cells","volume":"3","author":"Gillespie","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0235","first-page":"81","article-title":"3-O-angeloylingenol, the toxic and skin irritant factor from latex of Euphorbia antiquorum L. (Euphorbiaceae) and from a derived Thai purgative and anthelimintic (vermifuge) drug","volume":"9","author":"Adolf","year":"1983","journal-title":"J Sci Soc"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0240","first-page":"5009","article-title":"Cross sensitivity to methylating agents, hydroxyurea, and methotrexate in human tumor cells of the Mer phenotype","volume":"46","author":"Maynard","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0245","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1158\/0008-5472.CAN-03-3403","article-title":"Characterization of the interaction of ingenol 3-angelate with protein kinase C","volume":"64","author":"Kedei","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0250","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/1535-7163.MCT-07-2060","article-title":"Effects of protein kinase C modulation by PEP005, a novel ingenol angelate, on mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling in cancer cells","volume":"7","author":"Serova","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0255","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2004-10-4117","article-title":"PEP005, a selective small-molecule activator of protein kinase C has potent antileukemic activity mediated via the delta isoform of PKC","volume":"106","author":"Hampson","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0260","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-03-2837","article-title":"Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death","volume":"64","author":"Ogbourne","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0265","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/toxins2010174","article-title":"The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity","volume":"2","author":"Ersvaer","year":"2010","journal-title":"Toxins"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0270","doi-asserted-by":"crossref","first-page":"8123","DOI":"10.4049\/jimmunol.177.11.8123","article-title":"Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate","volume":"177","author":"Challacombe","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0275","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/jid.2011.418","article-title":"Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches","volume":"132","author":"Cozzi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0280","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1021\/jm050321r","article-title":"Discovery and biological evaluation of the novel naturally occurring diterpene pepluanone as antiinflammatory agent","volume":"48","author":"Corea","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0285","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jsps.2016.06.003","article-title":"Biologically-guided isolation of leishmanicidal secondary metabolites from Euphorbia peplus L","volume":"25","author":"Amin","year":"2017","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0290","doi-asserted-by":"crossref","first-page":"928","DOI":"10.5694\/j.1326-5377.1976.tb141173.x","article-title":"Home treatment of basal cell carcinoma","volume":"1","author":"Weedon","year":"1976","journal-title":"Med J Aust"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0295","first-page":"633","article-title":"The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers","volume":"164","author":"Ramsay","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0300","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1440-0960.2008.00497.x","article-title":"PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study","volume":"50","author":"Siller","year":"2009","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0305","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jaad.2009.01.008","article-title":"Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis","volume":"60","author":"Anderson","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0310","first-page":"866","article-title":"Which plant for which skin disease? Part 2: dermatophytes, chronic venous insufficiency, photoprotection, actinic keratoses, vitiligo, hair loss, cosmetic indications","volume":"8","author":"Reuter","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0315","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamadermatol.2013.2766","article-title":"Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses","volume":"149","author":"Lebwhol","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0320","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3390\/antib1010039","article-title":"Antibody-based immunotoxins for the treatment of cancer","volume":"1","author":"Becker","year":"2012","journal-title":"Antibodies"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0325","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1001\/jama.294.18.2342","article-title":"Ricin poisoning: a comprehensive review","volume":"294","author":"Audi","year":"2005","journal-title":"JAMA"},{"year":"2009","series-title":"Bioterrorism and Infectious Agents: A New Dilemma for the 21st Century","author":"Fong","key":"10.1016\/j.clindermatol.2018.03.013_bb0330"},{"year":"2016","series-title":"Biological Weapons: Recognizing, Understanding, and Responding to the Threat","author":"Johnson","key":"10.1016\/j.clindermatol.2018.03.013_bb0335"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0340","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1021\/bi00740a028","article-title":"Different biological properties of the two constituent peptide chains of ricin, a toxic protein inhibiting protein synthesis","volume":"12","author":"Olsnes","year":"1973","journal-title":"Biochemistry"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0345","doi-asserted-by":"crossref","first-page":"19264","DOI":"10.1074\/jbc.M307049200","article-title":"Ricin triggers apoptotic morphological changes through caspase-3 cleavage of BAT","volume":"279","author":"Wu","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0350","unstructured":"Tesh VL. The Induction of Apoptosis by Shiga Toxins and Ricin. Ricin and Shiga Toxins. Berlin: Springer."},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0355","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.bcp.2004.11.010","article-title":"Mechanism of ricin-induced apoptosis in human cervical cancer cells","volume":"69","author":"Rao","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0360","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/256495a0","article-title":"Continuous cultures of fused cells secreting antibody of predefined specificity","volume":"256","author":"K\u00f6hler","year":"1975","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0365","first-page":"1","article-title":"Antibody carriers of drugs and toxins in tumor therapy","volume":"62","author":"Arnon","year":"1982","journal-title":"Immunol Rev"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0370","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1182\/blood.V82.9.2624.bloodjournal8292624","article-title":"A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy","volume":"82","author":"Amlot","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0375","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood.V89.2.403","article-title":"A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin\u2019s lymphoma","volume":"89","author":"Engert","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0380","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/annonc\/mdg209","article-title":"Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin\u2019s lymphoma","volume":"14","author":"Schnell","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0385","first-page":"1302","article-title":"A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma","volume":"6","author":"Messmann","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0390","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ijc.2910300410","article-title":"Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97","volume":"30","author":"Casellas","year":"1982","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0395","first-page":"1717","article-title":"Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin","volume":"47","author":"Spitler","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0400","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1743-422X-6-17","article-title":"Production and purification of immunologically active core protein p24 from HIV-1 fused to ricin toxin B subunit in E. coli","volume":"6","author":"Donayre-Torres","year":"2009","journal-title":"Virol J"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0405","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/227292a0","article-title":"Abrin and ricin: new anti-tumour substance","volume":"227","author":"Lin","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0410","first-page":"862","article-title":"Phase I study of the plant protein ricin","volume":"44","author":"Fodstad","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0415","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1073\/pnas.77.9.5483","article-title":"Anti-Thy 1.2 monoclonal antibody linked to ricin is a potent cell-type-specific toxin","volume":"77","author":"Youle","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0420","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/297594a0","article-title":"Selective killing of malignant cells in a leukaemic rat bone marrow using an antibody-ricin conjugate","volume":"297","author":"Thorpe","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0425","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.6353579","article-title":"Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies","volume":"222","author":"Vallera","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0430","first-page":"4062","article-title":"Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate","volume":"49","author":"Weiner","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0435","first-page":"258","article-title":"Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients","volume":"75","author":"Durrant","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0440","first-page":"97","article-title":"A phase I study of T101-ricin A chain immunotoxin in refractory chronic lymphocytic leukemia","volume":"7","author":"Hertler","year":"1988","journal-title":"J Biol Response Mod"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0445","first-page":"6236","article-title":"An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use","volume":"51","author":"Lambert","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0450","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0304-4165(81)90264-6","article-title":"A comparison of the accumulation of ricin by hepatic parenchymal and non-parenchymal cells and its inhibition of protein synthesis","volume":"677","author":"Skilleter","year":"1981","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0455","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1634\/theoncologist.2014-0358","article-title":"Advances in anticancer immunotoxin therapy","volume":"20","author":"Alewine","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0460","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1073\/pnas.96.7.3957","article-title":"Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome","volume":"96","author":"Baluna","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0465","doi-asserted-by":"crossref","first-page":"9514","DOI":"10.1073\/pnas.91.20.9514","article-title":"Prevention of immunotoxin-mediated vascular leak syndrome in rats with retention of antitumor activity","volume":"91","author":"Siegall","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0470","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3816\/CLM.2001.n.005","article-title":"Biological correlates of acute hypersensitivity events with DAB(389)IL-2 (denileukin diftitox, ONTAK) in cutaneous T-cell lymphoma: decreased frequency and severity with steroid premedication","volume":"1","author":"Foss","year":"2001","journal-title":"Clin Lymphoma"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/LPI.S40233","article-title":"Castor oil: properties, uses, and optimization of processing parameters in commercial production","volume":"9","author":"Patel","year":"2016","journal-title":"Lipid Insights"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0480","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10915810701663150","volume":"26","year":"2007","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0485","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0378-8741(82)90038-1","article-title":"Verious uses of the castor oil plant (Ricinus communis L.). A review","volume":"5","author":"Scarpa","year":"1982","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0490","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5487\/TR.2015.31.2.105","article-title":"Safety evaluation of polyethylene glycol (PEG) compounds for cosmetic use","volume":"31","author":"Jang","year":"2015","journal-title":"Toxicol Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0495","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1365-2133.2009.09602.x","article-title":"Dirt-binding particles consisting of hydrogenated castor oil beads constitute a nonirritating alternative for abrasive cleaning of recalcitrant oily skin contamination in a three-step programme of occupational skin protection","volume":"162","author":"Mahler","year":"2010","journal-title":"Br J Derematol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0500","first-page":"611","article-title":"Phenol-castor oil: modified peel for dermal melasma","volume":"32","author":"Piamphongsant","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0505","first-page":"60","article-title":"Using a castor oil-balsam of Peru-trypsin ointment to assist in healing skin graft donor sites","volume":"49","author":"Carson","year":"2003","journal-title":"Ostomy Wound Manage"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0510","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1067\/mjd.2002.125081","article-title":"Useful plants of dermatology. VI. The mayapple (Podophyllum)","volume":"47","author":"Schwartz","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0515","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1001\/jamadermatol.2015.6301","article-title":"History of podophyllin","volume":"152","author":"Maatouk","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0520","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3724\/SP.J.1009.2012.00161","article-title":"Podophyllotoxin, a medicinal agent of plant origin: past, present and future","volume":"10","author":"Guerram","year":"2012","journal-title":"Chin J Nat Med"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0525","first-page":"388","article-title":"Condyloma acuminata","volume":"94","author":"Kaplan","year":"1942","journal-title":"New Orleans Med Surg J"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0530","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1021\/np50024a015","article-title":"An investigation of the antiviral activity of Podophyllum peltatum","volume":"45","author":"Bedows","year":"1982","journal-title":"J Nat Prod"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0535","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1099\/00222615-45-3-167","article-title":"Studies to show that with podophyllotoxin the early replicative stages of herpes simplex virus type 1 depend upon functional cytoplasmic microtubules","volume":"45","author":"Hammonds","year":"1996","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0540","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1021\/bi00670a003","article-title":"Effects of podophyllotoxin and VP-16-213 on microtubule assembly in vitro and nucleoside transport in HeLa cells","volume":"15","author":"Loike","year":"1976","journal-title":"Biochemistry"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0545","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/1359-6446(96)10028-3","article-title":"Podophyllotoxin derivatives: drug discovery and development","volume":"1","author":"Bohlin","year":"1996","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0550","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000247309","article-title":"Topical podophyllotoxin in psoriasis vulgaris","volume":"186","author":"Wantke","year":"1993","journal-title":"Dermatology"},{"year":"2011","series-title":"Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures","author":"Minev","key":"10.1016\/j.clindermatol.2018.03.013_bb0555"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0560","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4236\/jcdsa.2015.53023","article-title":"Treatment of basal cell carcinoma by topical 25% podophyllin solution","volume":"5","author":"Sharquie","year":"2015","journal-title":"JCDSA"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0565","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00000658-194408000-00012","article-title":"Condylomata acuminata: two hundred cases treated with podophyllin","volume":"120","author":"Culp","year":"1944","journal-title":"Ann Surg"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0570","first-page":"5","article-title":"An evidence-based review of medical and surgical treatments of genital warts","volume":"12","author":"Scheinfeld","year":"2006","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0575","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/sti.77.6.409","article-title":"Podophyllin office therapy against condyloma should be abandoned","volume":"77","author":"von Krogh","year":"2001","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0580","first-page":"263","article-title":"Podophyllotoxin 0.5% v podophyllin 20% to treat penile warts","volume":"64","author":"Edwards","year":"1988","journal-title":"Genitourin Med"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0585","first-page":"16","article-title":"Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation","volume":"66","author":"Stone","year":"1990","journal-title":"Genitourin Med"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0590","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1212\/WNL.32.3.308","article-title":"Neurologic manifestations of podophyllin toxicity","volume":"32","author":"Filley","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0595","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/15563658008989950","article-title":"Podophyllum: suspected teratogenicity from topical application","volume":"16","author":"Karol","year":"1980","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0600","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/sti.79.4.270","article-title":"Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts","volume":"79","author":"Lacey","year":"2003","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0605","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1468-3083.1997.tb00198.x","article-title":"Assesment of self application of four topical agents on genital warts in women","volume":"8","author":"Frega","year":"1997","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0610","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000249369","article-title":"Response of solitary psoriatic plaques to experimental application of podophyllotoxin","volume":"172","author":"Lassus","year":"1986","journal-title":"Dermatologica"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0615","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/rheumatology\/39.3.316","article-title":"A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis","volume":"39","author":"Lerndal","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0620","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1021\/jf5005622","article-title":"Cyclopamine: from cyclops lambs to cancer treatment","volume":"62","author":"Lee","year":"2014","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0625","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1016\/j.bmc.2016.06.017","article-title":"Cyclopamine bioactivity by extraction method from Veratrum californicum","volume":"24","author":"Turner","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0630","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2174\/15680096113139990003","article-title":"Inhibition of hedgehog\/Gli signaling by botanicals: a review of compounds with potential hedgehog pathway inhibitory activities","volume":"13","author":"Drenkhahn","year":"2013","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0635","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12885-017-3286-5","article-title":"Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study","volume":"17","author":"Sekulic","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0640","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaad.2016.02.1226","article-title":"The 12-month analysis from basal cell carcinoma outcomes with LDE225 treatment (BOLT): a phase II, randomized, double-blind study of sonidegib in patients with advanced basal cell carcinoma","volume":"75","author":"Dummer","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0645","doi-asserted-by":"crossref","first-page":"537","DOI":"10.6004\/jnccn.2017.0051","article-title":"Implementation of systemic hedgehog inhibitors in daily practice as neoadjuvant therapy","volume":"15","author":"Tang","year":"2017","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0650","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S1470-2045(16)30566-6","article-title":"Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"17","author":"Tang","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0655","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-209333","article-title":"Accidental overdose in the deep shade of night: a warning on the assumed safety of \u2018natural substances\u2019","volume":"2015","author":"Chadwick","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0660","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/jid.2015.29","article-title":"Activity-guided purification identifies lupeol, a pentacyclic triterpene, as a therapeutic agent multiple pathogenic factors of acne","volume":"135","author":"Kwon","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0665","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jep.2015.12.036","article-title":"Topical anti-inflammatory activity of Solanum corymbiflorum leaves","volume":"179","author":"Piana","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0670","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3746\/pnf.2016.21.2.110","article-title":"Antioxidant contents and antioxidant activities of white and colored potatoes (Solanum tuberosum L.)","volume":"21","author":"Lee","year":"2016","journal-title":"Prev Nutr Food Sci"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0675","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.3892\/mmr.2016.5595","article-title":"Solanum tuberosum L. cv Hongyoung extract inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC\/Nga mice","volume":"14","author":"Kang","year":"2016","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0680","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jep.2016.12.046","article-title":"Anti-psoriatic potential of Solanum xanthocarpum stem in Imiquimod-induced psoriatic mice model","volume":"198","author":"Parmar","year":"2017","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0685","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.clindermatol.2010.03.021","article-title":"Tobacco and the skin","volume":"28","author":"Metelitsa","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0690","first-page":"4","article-title":"Smoking and skin disease","volume":"15","author":"Thomsen","year":"2010","journal-title":"Skin Ther Lett"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0695","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amsu.2016.03.028","article-title":"Thromboangiitis obliterans (Buerger\u2019s disease)","volume":"7","author":"Rivera-chavarr\u00eda","year":"2016","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0700","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s100670070020","article-title":"Smoking and Beh\u00e7et\u2019s disease","volume":"19","author":"Soy","year":"2000","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0705","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1056\/NEJM200012143432418","article-title":"Nicotine patches for aphthous ulcers due to Beh\u00e7et\u2019s syndrome","volume":"343","author":"Scheid","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0710","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.jid.5700492","article-title":"Nicotine and biochanin A, but not cigarette smoke, induce anti-inflammatory effects on keratinocytes and endothelial cells in patients with Beh\u00e7et\u2019s disease","volume":"127","author":"Kalayciyan","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0715","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archderm.136.1.15","article-title":"A case of pemphigus vulgaris improved by cigarette smoking","volume":"136","author":"Mehta","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0720","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM199403243301202","article-title":"Transdermal nicotine for active ulcerative colitis","volume":"330","author":"Pullan","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0725","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/archderm.134.9.1071","article-title":"Nicotine for pyoderma gangrenosum","volume":"134","author":"Wolf","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0730","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1021\/acs.jafc.5b00818","article-title":"Chemistry and anticarcinogenic mechanisms of glycoalkaloids produced by eggplants, potatoes, and tomatoes","volume":"63","author":"Friedman","year":"2015","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0735","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.2147\/DDDT.S119214","article-title":"Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cells","volume":"10","author":"Ling","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0740","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4236\/jct.2013.42076","article-title":"Solasodine glycosides: a topical therapy for actinic keratosis. a single-blind, randomized, placebo-controlled, parallel group study with CuradermBEC5","volume":"4","author":"Cham","year":"2013","journal-title":"J Cancer Ther"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0745","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1365-4632.2007.03363.x","article-title":"Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicenter study","volume":"47","author":"Punjabi","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0750","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0378-8741(92)90011-F","article-title":"Solanum chrysotrichum (Schldl.) a plant used in Mexico for the treatment of skin mycosis","volume":"36","author":"Lozoya","year":"1992","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0755","first-page":"410","article-title":"Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences","volume":"10","author":"Herrera-arellano","year":"2013","journal-title":"Afr J Tradit Complement Altern Med"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0760","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0378-8741(02)00195-2","article-title":"Healing potential of Datura alba on burn wounds in albino rats","volume":"83","author":"Priya","year":"2002","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0765","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/00042728-200712000-00003","article-title":"Hydrophilic polymers with potassium salt and microporous polysaccharides for use as hemostatic agents","volume":"33","author":"Ho","year":"2007","journal-title":"Derm Surg"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0770","first-page":"908","article-title":"Effectiveness of microporous polysaccharide hemospheres for achieving hemostasis in Mohs micrographic surgery","volume":"30","author":"Tan","year":"2004","journal-title":"Derm Surg"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0775","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0738-081X(98)00070-4","article-title":"Traditional Indian medicine in dermatology","volume":"17","author":"Routh","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0780","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archotol.128.7.847","article-title":"Scopolamine and the murder of King Hamlet","volume":"128","author":"Kotsias","year":"2002","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0785","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamadermatol.2014.357","article-title":"Leprology and betrayal in Shakespeare\u2019s Hamlet","volume":"150","author":"Guo","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0790","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2307\/4568999","article-title":"The prevalence and geographic distribution of pellagra in the United States","volume":"27","author":"Lavinder","year":"1912","journal-title":"Public Health Rep"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0795","first-page":"211","article-title":"Politics and pellagra: the epidemic of pellagra in the US in the early twentieth century","volume":"65","author":"Bollet","year":"1992","journal-title":"Yale J Biol Med"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0800","first-page":"58","volume":"2","year":"1938","journal-title":"LIFE"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0805","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/jama.1956.72970340006010","article-title":"A brief history of the enrichment of bread and flour","volume":"162","author":"Wilder","year":"1956","journal-title":"JAMA"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0810","first-page":"88","article-title":"Introduction of tobacco in popular medicine of the country in treatment of pellagra in the preceding century","volume":"9","author":"Vasilev","year":"1958","journal-title":"Suvr Med"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0820","first-page":"403","article-title":"Why is it called \u201cbeautiful lady\u201d? A note on belladonna","volume":"53","author":"Forbes","year":"1977","journal-title":"Bull N Y Acad Med"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0825","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1017\/S0025727300000235","article-title":"\u201cDivine stramonium\u201d: the rise and fall of smoking for asthma","volume":"54","author":"Jackson","year":"2010","journal-title":"Med Hist"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0830","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0041-008X(02)00014-5","article-title":"Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice","volume":"186","author":"Afaq","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0835","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.abb.2010.12.030","article-title":"The grape antioxidant resveratrol for skin disorders: Promise, prospects, and challenges","volume":"508","author":"Ndiyae","year":"2011","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0840","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/0140-6736(92)91277-F","article-title":"Wine, alcohol, platelets, and the French paradox for coronary heart disease","volume":"339","author":"Renaud","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0845","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1126\/science.275.5297.218","article-title":"Cancer chemopreventive activity of resveratrol, a natural product derived from grapes.","volume":"275","author":"Jang","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0850","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1021\/acs.jnatprod.5b01132","article-title":"Resveratrol-loaded liquid-crystalline system inhibits UVB-induced skin inflammation and oxidative stress in mice","volume":"79","author":"Fujimura","year":"2016","journal-title":"J Nat Prod"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0855","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1038\/sj.onc.1207666","article-title":"Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin","volume":"23","author":"Reagan-Shaw","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0860","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1476-5586(03)80019-2","article-title":"Suppression of ultraviolet B exposure-mediated activation of NF-\u03baB in normal human keratinocytes by resveratrol","volume":"5","author":"Adhami","year":"2003","journal-title":"Neoplasia"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0865","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2010.10.009","article-title":"Resveratrol protects human keratinocytes HaCaT cells from UVA-induced oxidative stress damage by downregulating Keap1 expression","volume":"650","author":"Liu","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0870","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijpharm.2016.09.014","article-title":"Effect of quercetin and resveratrol co-incorporated in liposomes against inflammatory\/oxidative response associated with skin cancer","volume":"513","author":"Caddeo","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0875","first-page":"2935","article-title":"Administration of resveratrol enhances cell-cycle arrest followed by apoptosis in DMBA-induced skin carcinogenesis in male Wister rats","volume":"20","author":"Hu","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0880","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3390\/molecules22030474","article-title":"Anti-cancer activity of resveratrol and derivatives produced by grapevine cell suspensions in a 14 L stirred bioreactor","volume":"22","author":"Nivelle","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0885","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jss.2010.07.033","article-title":"Enhancing melanoma treatment with resveratrol","volume":"172","author":"Osmond","year":"2012","journal-title":"J Surg Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0890","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/CMR.0000000000000016","article-title":"Chemoprevention of skin melanoma: Facts and myths","volume":"23","author":"Uzarska","year":"2013","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0895","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.phymed.2016.10.016","article-title":"Anti-metastatic potential of resveratrol and its metabolites by the inhibition of epithelial-mesenchymal transition, migration, and invasion of malignant cancer cells","volume":"23","author":"Kim","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0900","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2003.07.001","article-title":"Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice","volume":"61","author":"Docherty","year":"2004","journal-title":"Antivir Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0905","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13046-016-0398-8","article-title":"Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by resveratrol","volume":"35","author":"Fuggetta","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0910","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1016\/j.bmcl.2016.05.068","article-title":"Synthesis and skin gene analysis of 4\u2032-acetoxy-resveratrol (4AR), therapeutic potential for dermal applications","volume":"26","author":"Lephart","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0915","doi-asserted-by":"crossref","first-page":"e12935","DOI":"10.1371\/journal.pone.0012935","article-title":"Protective action of resveratrol in human skin: possible involvement of specific receptor binding sites","volume":"5","author":"Bastianetto","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0920","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/DSS.0000000000000921","article-title":"The combination of resveratrol and high-fluence light emitting diode-red light produces synergistic photobotanical inhibition of fibroblast proliferation and collagen synthesis: a novel treatment for skin fibrosis","volume":"43","author":"Mamalis","year":"2017","journal-title":"Derm Surg"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0925","article-title":"Effects of resveratrol on the expression of molecules related to the mTOR signaling pathway in pathological scar fibroblasts","author":"Tang","year":"2017","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0930","first-page":"770","article-title":"Reduction of facial redness with resveratrol added to topical product containing green tea polyphenols and caffeine","volume":"12","author":"Ferzli","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0935","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0304-3835(02)00676-6","article-title":"Resveratrol is a potent inducer of apoptosis in human melanoma cells","volume":"190","author":"Niles","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0940","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1021\/jf030073c","article-title":"Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition,apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells","volume":"51","author":"Larrosa","year":"2003","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0945","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.bbrc.2005.06.073","article-title":"Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53","volume":"334","author":"Hsieh","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0950","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/47.2.243","article-title":"Resveratrol selectively inhibits Neisseria gonorrhoeae and Neisseria meningitidis","volume":"47","author":"Docherty","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0955","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2006.06.011","article-title":"Resveratrol suppresses nuclear factor-\u03baB in herpes simplex virus infected cells","volume":"72","author":"Faith","year":"2006","journal-title":"Antivir Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0960","first-page":"1467","article-title":"Evaluation of efficacy and tolerance of a nighttime topical antioxidant containing resveratrol, baicalin, and vitamin e for treatment of mild to moderately photodamaged skin","volume":"13","author":"Farris","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0965","first-page":"476","article-title":"Enhancing topical delivery of resveratrol through a nanosizing approach","volume":"83","author":"Sinico","year":"2017","journal-title":"Planta Med"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0970","doi-asserted-by":"crossref","first-page":"4048764","DOI":"10.1155\/2016\/4048764","article-title":"Coca: the history and medical significance of an ancient Andean tradition","volume":"2016","author":"Biondich","year":"2016","journal-title":"Emerg Med Int"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0975","first-page":"CD005364","article-title":"Topical anaesthetics for pain control during repair of dermal laceration (Review)","volume":"22","author":"Tayeb","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0980","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/lary.21286","article-title":"Systematic review of topical vasoconstrictors in endoscopic sinus surgery","volume":"121","author":"Higgins","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0985","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.explore.2005.12.011","article-title":"Can mushrooms help save the world? Interview by Bonnie J. Horrigan","volume":"2","author":"Stamets","year":"2006","journal-title":"Explore"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0990","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jep.2014.04.030","article-title":"European medicinal polypores\u2014a modern view on traditional uses","volume":"154","author":"Grienke","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb0995","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1017\/S0953756298006546","article-title":"The Iceman\u2019s fungi","volume":"102","author":"Peintner","year":"1998","journal-title":"Mycol Res"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb1000","doi-asserted-by":"crossref","first-page":"e0140355","DOI":"10.1371\/journal.pone.0140355","article-title":"Antibacterial, antiradical potential and phenolic compounds of thirty-one polish mushrooms","volume":"110","author":"Nowacka","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb1005","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00253-010-3067-4","article-title":"Current findings, future trends, and unsolved problems in studies of medicinal mushrooms","volume":"89","author":"Wasser","year":"2011","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb1010","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1021\/np300412h","article-title":"Lanostanoids from fungi: a group of potential anti cancer compounds","volume":"75","author":"Rios","year":"2012","journal-title":"J Nat Prod"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb1015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.phytochem.2013.05.003","article-title":"Fomentarols A-D,s terols from the polypore macrofungus Fomes fomentarius","volume":"92","author":"Zang","year":"2013","journal-title":"Phytochemistry"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb1020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11274-016-2114-4","article-title":"Cultivation and utility of Piptoporus betulinus fruiting bodiesas a source of anticancer agents","volume":"32","author":"Pleszczy\u0144ska","year":"2016","journal-title":"World J Microbiol Biotechnol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb1025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1615\/IntJMedMushrooms.v17.i12.10","article-title":"Did the iceman know better? Screening of the medicinal properties of the birch polypore medicinal mushroom, Piptoporus betulinus (Higher Basidiomycetes)","volume":"17","author":"Vunduk","year":"2015","journal-title":"Int J Med Mushrooms"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb1030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ajp.2016.08.010","article-title":"Return of the psychedelics: Psilocybin for treatment resistant depression","volume":"24","author":"Patra","year":"2016","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb1035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb1040","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/0269881114548296","article-title":"Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction","volume":"28","author":"Johnson","year":"2014","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clindermatol.2018.03.013_bb1045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7453\/gahmj.2012.1.5.008","article-title":"Complete and spontaneous regression of merkel cell carcinoma metastatic to the liver: did lifestyle modifications and dietary supplements play a role","volume":"1","author":"Vandeven","year":"2012","journal-title":"Glob Adv Health Med"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X1830049X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X1830049X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T01:58:38Z","timestamp":1751507918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X1830049X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":201,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0738081X1830049X"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2018.03.013","relation":{},"ISSN":["0738-081X"],"issn-type":[{"type":"print","value":"0738-081X"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dangerous plants in dermatology: Legal and controlled","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2018.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}